Japanese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Acta Medica Croatica 2009-Oct

[Lysosomes and apoptosis].

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
リンクがクリップボードに保存されます
Drazen Vikić-Topić
Olga Carević

キーワード

概要

In 1955, Christian de Duve and his coworkers from the School of Medicine in Louvain, Belgium, named a group of cytoplasmic formations surrounded by lipoprotein membrane and containing acid hydrolase enzymes as lysosomes. Biochemical and cytochemical studies showed lysosomes to be found in animal and vegetable eukaryotic cells. Later on, lysosomes were found to be involved in the dynamics of lysosomal system, which consists of a number of various cytoplasmic formations such as primary and secondary lysosomes, endosomes, autophagosomes and postlysosomes. These formations are inter-connected by the mechanism of membrane integration, and in some instances by the cell membrane. Lysosomal system is involved in numerous physiological processes such as degradation of endogenous and exogenous macromolecules (proteins, lipids, polysaccharides and nucleic acids), cytoplasmic formations (mitochondria, peroxisomes, Golgi complex) that have performed their functions, tissue regression (post-lactation mammary gland), hormone secretion regulation (proinsulin to insulin), etc. On the other hand, lysosomal system is also involved in a number of pathologic processes like inflammation, allergic reactions, ischemia, hypoxia, as well as in lysosomal diseases (thesaurismoses), e.g., type II glycogenosis, fucosidosis, mucolipidosis III, etc. In 1974, Christian de Duve introduced the term lysosomotropism, denoting entry of the pharmacologically active, toxic and carcinogenic substances in the lysosomal system irrespective of their chemical nature and mechanism of input. Lysosomotropic substances may act in two ways: (1) causing impairments in the intralysosomal area, with toxic manifestations; and (2) modifying their membrane properties by increasing or decreasing membrane permeability, or by inducing labilizing or stabilizing effects. Damage to the lysosomal system occurs in the late stage of necrosis, while destabilization of lysosomal formations has been recorded in primary processes during apoptosis.

Facebookページに参加する

科学に裏打ちされた最も完全な薬草データベース

  • 55の言語で動作します
  • 科学に裏打ちされたハーブ療法
  • 画像によるハーブの認識
  • インタラクティブGPSマップ-場所にハーブをタグ付け(近日公開)
  • 検索に関連する科学出版物を読む
  • それらの効果によって薬草を検索する
  • あなたの興味を整理し、ニュース研究、臨床試験、特許について最新情報を入手してください

症状や病気を入力し、役立つ可能性のあるハーブについて読み、ハーブを入力して、それが使用されている病気や症状を確認します。
*すべての情報は公開された科学的研究に基づいています

Google Play badgeApp Store badge